Neurocrine Bioscienc
(NBIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 37,000 | 21,100 | -142,542 | -141,090 | -88,929 |
| Depreciation Amortization | 27,700 | 22,900 | 15,941 | 4,973 | 7,041 |
| Accounts receivable | -69,200 | -25,100 | -31,127 | N/A | N/A |
| Other Working Capital | -4,800 | -1,700 | -8,807 | 5,781 | 8,703 |
| Other Operating Activity | 156,300 | 84,200 | 72,204 | 24,155 | 35,188 |
| Operating Cash Flow | $147,000 | $101,400 | $-94,331 | $-106,181 | $-37,997 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -196,400 | -218,100 | -244,320 | 117,050 | -193,929 |
| PPE Investments | -14,700 | -24,800 | -6,933 | -4,095 | -1,925 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 40 |
| Investing Cash Flow | $-211,100 | $-242,900 | $-251,253 | $112,955 | $-195,814 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 502,781 | N/A | N/A |
| Common Stock Issued | 32,400 | 29,500 | 13,865 | 2,390 | 276,992 |
| Financing Cash Flow | $32,400 | $29,500 | $516,646 | $2,390 | $276,992 |
| Beginning Cash Position | 147,200 | 259,200 | 88,150 | 78,986 | 31,014 |
| End Cash Position | 115,500 | 147,200 | 259,212 | 88,150 | 74,195 |
| Net Cash Flow | $-31,700 | $-112,000 | $171,062 | $9,164 | $43,181 |
| Free Cash Flow | |||||
| Operating Cash Flow | 147,000 | 101,400 | -94,331 | -106,181 | -37,997 |
| Capital Expenditure | -14,700 | -24,800 | -6,940 | -4,108 | -1,934 |
| Free Cash Flow | 132,300 | 76,600 | -101,271 | -110,289 | -39,931 |